Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide
Taudorf, S; Berg, RMG; Bailey, DM; Moller, K
| HERO ID | 620825 |
|---|---|
| In Press | No |
| Year | 2009 |
| Title | Cerebral blood flow and oxygen metabolism measured with the Kety-Schmidt method using nitrous oxide |
| Authors | Taudorf, S; Berg, RMG; Bailey, DM; Moller, K |
| Journal | Acta Anaesthesiologica Scandinavica |
| Volume | 53 |
| Issue | 2 |
| Page Numbers | 159-167 |
| Abstract | The Kety-Schmidt method is the reference method for measuring global cerebral blood flow (CBF), cerebral metabolic rates (CMR) and flux, especially where scanners are unavailable or impractical. Our primary objective was to assess the repeatability of the Kety-Schmidt method in a variety of different approaches using inhaled nitrous oxide (N2O) as the tracer, combined with photoacoustic spectrometry. A secondary objective was to assess the impact of this tracer on the systemic vascular concentration of nitrite (NO2-). Twenty-nine healthy male volunteers underwent 61 CBF measurements by breathing a normoxic gas mixture containing 5% N2O until tension equilibrium. Paired blood samples were collected from an arterial and a jugular bulb catheter in the saturation or desaturation phase, by continuous or the discontinuous sampling. N2O concentration was measured with photoacoustic spectrometry after equilibration of blood samples with air. CBF was calculated by the Kety-Schmidt equation. CMR of oxygen (CMRO2) was determined by the Fick principle. NO2- in plasma and red blood cells (RBC) was measured by ozone-based chemiluminescence. The most robust approach for CBF measurement was achieved by discontinuous sampling in the desaturation phase [CBF, 64 (95% confidence interval, 59-71 ml)] 100 g/min; CMRO2 1.8 (1.7-2.0) mu mol/g/min). The tracer did not influence plasma or RBC NO2- (P > 0.05 vs. baseline). These findings confirm the reliability and robustness of the Kety-Schmidt method using inhaled N2O for the measurement of global CBF and CMR. At the low tracer concentration used, altered NO metabolism is unlikely to have affected cerebral haemodynamic function. |
| Doi | 10.1111/j.1399-6576.2008.01788.x |
| Pmid | 19076112 |
| Wosid | WOS:000262515200003 |
| Is Certified Translation | No |
| Dupe Override | No |
| Comments | Source: Web of Science WOS:000262515200003 |
| Is Public | Yes |
| Language Text | English |
| Is Qa | No |